Al Salmi Amal, Al Shibli Abdullah, Al-Saadi Maimuna
Dermatology, Al Buraimi Hospital, Al Buraimi, OMN.
Family Medicine, Oman Medical Specialty Board, Muscat, OMN.
Cureus. 2025 Feb 1;17(2):e78336. doi: 10.7759/cureus.78336. eCollection 2025 Feb.
Following the widespread distribution of COVID-19 vaccines, a range of side effects have been reported globally. These effects range from mild reactions, such as injection site discomfort and fever, to rarer events like allergic responses. While most side effects have been mild and transient, their occurrence has prompted further investigation into their frequency, severity, and underlying mechanisms. Despite the generally favorable safety profile of current vaccines, ongoing research remains essential to ensuring their continued safety and effectiveness across diverse populations. In this paper, we present the case of a 25-year-old female diagnosed with purpura annularis telangiectodes of Majocchi following a booster dose of the Pfizer-BioNTech COVID-19 mRNA vaccine. Whether this represents a causal association or a coincidental occurrence warrants further investigation.
随着新冠病毒疫苗的广泛接种，全球范围内报告了一系列副作用。这些副作用从轻微反应，如注射部位不适和发热，到罕见的过敏反应等。虽然大多数副作用轻微且短暂，但它们的出现促使人们进一步研究其发生频率、严重程度及潜在机制。尽管目前的疫苗总体安全性良好，但持续研究对于确保其在不同人群中的持续安全性和有效性仍然至关重要。在本文中，我们报告了一例25岁女性在接种辉瑞 - 生物科技公司的新冠mRNA加强疫苗后被诊断为马约基环形毛细血管扩张性紫癜的病例。这是因果关联还是巧合事件，值得进一步研究。
